| Primary |
| Parkinson's Disease |
57.4% |
| Parkinsonism |
7.4% |
| Antiviral Treatment |
3.7% |
| Asthma |
1.9% |
| Balance Disorder |
1.9% |
| Cardiovascular Event Prophylaxis |
1.9% |
| Depression |
1.9% |
| Dystonia |
1.9% |
| Essential Hypertension |
1.9% |
| Fatigue |
1.9% |
| Hepatitis C |
1.9% |
| Multiple Sclerosis |
1.9% |
| Muscle Spasticity |
1.9% |
| Pain |
1.9% |
| Product Used For Unknown Indication |
1.9% |
| Schizophrenia |
1.9% |
| Sleepiness |
1.9% |
| Tardive Dyskinesia |
1.9% |
| Thyroid Hormone Replacement Therapy |
1.9% |
| Wheezing |
1.9% |
|
| Completed Suicide |
10.3% |
| Toxicity To Various Agents |
10.3% |
| Visual Acuity Reduced |
10.3% |
| Mental Status Changes |
6.9% |
| Ventricular Tachycardia |
6.9% |
| Vision Blurred |
6.9% |
| Cholecystitis Acute |
3.4% |
| Disturbance In Attention |
3.4% |
| Dyskinesia |
3.4% |
| Hallucination, Visual |
3.4% |
| Hepatic Cirrhosis |
3.4% |
| Livedo Reticularis |
3.4% |
| Mucosal Dryness |
3.4% |
| Neutrophil Count Decreased |
3.4% |
| Pain In Extremity |
3.4% |
| Palpitations |
3.4% |
| Poisoning |
3.4% |
| Premature Delivery |
3.4% |
| Premature Labour |
3.4% |
| Pruritus |
3.4% |
|
| Secondary |
| Parkinson's Disease |
48.8% |
| Depression |
9.9% |
| Product Used For Unknown Indication |
9.7% |
| Parkinsonism |
5.3% |
| Multiple Sclerosis |
4.4% |
| Psychotic Disorder |
3.4% |
| Hiccups |
2.9% |
| Rapid Eye Movements Sleep Abnormal |
2.5% |
| Hepatitis C |
1.9% |
| Paranoia |
1.7% |
| Suicide Attempt |
1.7% |
| Fatigue |
1.1% |
| H1n1 Influenza |
1.1% |
| Tardive Dyskinesia |
1.1% |
| Catatonia |
0.8% |
| Hallucination, Visual |
0.8% |
| Hypertension |
0.8% |
| Oral Disorder |
0.8% |
| Chronic Hepatitis C |
0.6% |
| Influenza |
0.6% |
|
| Orthostatic Hypotension |
13.0% |
| Tremor |
9.1% |
| Completed Suicide |
7.8% |
| Suicide Attempt |
6.5% |
| Vision Blurred |
6.5% |
| Respiratory Failure |
5.2% |
| Serotonin Syndrome |
5.2% |
| Ventricular Tachycardia |
5.2% |
| Weight Decreased |
5.2% |
| Amniotic Fluid Volume Decreased |
3.9% |
| Paranoia |
3.9% |
| Premature Baby |
3.9% |
| Psychotic Disorder |
3.9% |
| Suicidal Ideation |
3.9% |
| Withdrawal Syndrome |
3.9% |
| Drug Exposure Via Breast Milk |
2.6% |
| Drug Hypersensitivity |
2.6% |
| Drug Ineffective |
2.6% |
| Logorrhoea |
2.6% |
| Mucosal Dryness |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
36.7% |
| Multiple Sclerosis |
22.0% |
| Parkinson's Disease |
10.8% |
| Pain |
3.8% |
| Depression |
3.6% |
| Fatigue |
3.6% |
| Hypertension |
3.4% |
| Relapsing-remitting Multiple Sclerosis |
2.2% |
| Schizophrenia |
1.9% |
| Osteoporosis |
1.5% |
| Gait Disturbance |
1.4% |
| Drug Use For Unknown Indication |
1.3% |
| Muscle Spasticity |
1.3% |
| Neuralgia |
1.3% |
| Diabetes Mellitus |
1.0% |
| Parkinsonism |
1.0% |
| Anxiety |
0.8% |
| Hormone Replacement Therapy |
0.8% |
| Pain In Extremity |
0.8% |
| Insomnia |
0.7% |
|
| Tremor |
11.7% |
| Urinary Tract Infection |
11.7% |
| Vomiting |
10.2% |
| Weight Decreased |
10.2% |
| Wound Infection Staphylococcal |
6.1% |
| Multiple Sclerosis Relapse |
5.6% |
| Flushing |
5.1% |
| Visual Impairment |
4.1% |
| Vision Blurred |
3.6% |
| Weight Increased |
3.6% |
| White Blood Cell Count Decreased |
3.6% |
| Death |
3.0% |
| Headache |
3.0% |
| Thrombosis |
3.0% |
| Wound Infection |
3.0% |
| Drug Ineffective |
2.5% |
| Multiple Sclerosis |
2.5% |
| Muscle Spasms |
2.5% |
| Paraesthesia |
2.5% |
| Pruritus |
2.5% |
|
| Interacting |
| Parkinson's Disease |
68.8% |
| Major Depression |
18.8% |
| Depression |
12.5% |
|
| Serotonin Syndrome |
100.0% |
|
